NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹136 Cr | ₹83 Cr | ₹122 Cr | ₹231 Cr | ₹170 Cr |
What is the latest Total Debt ratio of NEULAND LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹136 Cr |
| Mar2024 | ₹83 Cr |
| Mar2023 | ₹122 Cr |
| Mar2022 | ₹231 Cr |
| Mar2021 | ₹170 Cr |
How is Total Debt of NEULAND LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹136 Cr | 64.85 | |
| Mar2024 | ₹83 Cr | -32.10 | |
| Mar2023 | ₹122 Cr | -47.39 | |
| Mar2022 | ₹231 Cr | 35.71 | |
| Mar2021 | ₹170 Cr | - | |
Compare Total Debt of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹15,881.7 Cr | -1.3% | -6.3% | 12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -2.5% | 4.7% | 7.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -2.1% | -0.2% | 7.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -3.4% | 0.7% | 39.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -1.9% | 2% | 16.1% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -4.3% | -6.5% | -11.9% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1.3% |
-6.3% |
12% |
| SENSEX | -0.2% |
-7.2% |
3.5% |
You may also like the below Video Courses